Øyvind Holme1, Magnus Løberg1, Mette Kalager2, Michael Bretthauer1, Miguel A Hernán2, Eline Aas3, Tor J Eide1, Eva Skovlund4, Jon Lekven5, Jörn Schneede6, Kjell Magne Tveit7, Morten Vatn7, Giske Ursin8, Geir Hoff9. 1. Sørlandet Hospital Kristiansand, Kristiansand, Norway, and University of Oslo Institute of Health and Society and Oslo University Hospital, Oslo, Norway (Ø.H., M.L., M.B., T.J.E.). 2. University of Oslo Institute of Health and Society and Oslo University Hospital, Oslo, Norway, and Harvard T.H. Chan School of Public Health and Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts (M.K., M.A.H.). 3. Harvard T.H. Chan School of Public Health and Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts; University of Oslo Institute of Health and Society, Oslo, Norway (E.A.). 4. Oslo University Hospital, Oslo, Norway; orwegian University of Science and Technology, Trondheim, Norway (E.S.). 5. University of Bergen Surgical Research Laboratory, Bergen, Norway (J.L.). 6. Umeå University Clinical Pharmacology Unit, Umeå, Sweden (J.S.). 7. Oslo University Hospital and University of Oslo Institute of Clinical Medicine, Oslo, Norway (K.M.T., M.V.). 8. University of Oslo Institute of Clinical Medicine, Oslo, Norway; Cancer Registry of Norway and University of Oslo Institute of Basic Medical Sciences, Oslo, Norway, and University of Southern California Keck School of Medicine, Los Angeles, California (G.U.). 9. University of Oslo Institute of Clinical Medicine and Cancer Registry of Norway, Oslo, Norway, and Telemark Hospital, Skien, Norway (G.H.).
Abstract
Background: The long-term effects of sigmoidoscopy screening on colorectal cancer (CRC) incidence and mortality in women and men are unclear. Objective: To determine the effectiveness of flexible sigmoidoscopy screening after 15 years of follow-up in women and men. Design: Randomized controlled trial. (ClinicalTrials.gov: NCT00119912). Setting: Oslo and Telemark County, Norway. Participants: Adults aged 50 to 64 years at baseline without prior CRC. Intervention: Screening (between 1999 and 2001) with flexible sigmoidoscopy with and without additional fecal blood testing versus no screening. Participants with positive screening results were offered colonoscopy. Measurements: Age-adjusted CRC incidence and mortality stratified by sex. Results: Of 98 678 persons, 20 552 were randomly assigned to screening and 78 126 to no screening. Adherence rates were 64.7% in women and 61.4% in men. Median follow-up was 14.8 years. The absolute risks for CRC in women were 1.86% in the screening group and 2.05% in the control group (risk difference, -0.19 percentage point [95% CI, -0.49 to 0.11 percentage point]; HR, 0.92 [CI, 0.79 to 1.07]). In men, the corresponding risks were 1.72% and 2.50%, respectively (risk difference, -0.78 percentage point [CI, -1.08 to -0.48 percentage points]; hazard ratio [HR], 0.66 [CI, 0.57 to 0.78]) (P for heterogeneity = 0.004). The absolute risks for death from CRC in women were 0.60% in the screening group and 0.59% in the control group (risk difference, 0.01 percentage point [CI, -0.16 to 0.18 percentage point]; HR, 1.01 [CI, 0.77 to 1.33]). The corresponding risks for death from CRC in men were 0.49% and 0.81%, respectively (risk difference, -0.33 percentage point [CI, -0.49 to -0.16 percentage point]; HR, 0.63 [CI, 0.47 to 0.83]) (P for heterogeneity = 0.014). Limitation: Follow-up through national registries. Conclusion: Offering sigmoidoscopy screening in Norway reduced CRC incidence and mortality in men but had little or no effect in women. Primary Funding Source: Norwegian government and Norwegian Cancer Society.
RCT Entities:
Background: The long-term effects of sigmoidoscopy screening on colorectal cancer (CRC) incidence and mortality in women and men are unclear. Objective: To determine the effectiveness of flexible sigmoidoscopy screening after 15 years of follow-up in women and men. Design: Randomized controlled trial. (ClinicalTrials.gov: NCT00119912). Setting: Oslo and Telemark County, Norway. Participants: Adults aged 50 to 64 years at baseline without prior CRC. Intervention: Screening (between 1999 and 2001) with flexible sigmoidoscopy with and without additional fecal blood testing versus no screening. Participants with positive screening results were offered colonoscopy. Measurements: Age-adjusted CRC incidence and mortality stratified by sex. Results: Of 98 678 persons, 20 552 were randomly assigned to screening and 78 126 to no screening. Adherence rates were 64.7% in women and 61.4% in men. Median follow-up was 14.8 years. The absolute risks for CRC in women were 1.86% in the screening group and 2.05% in the control group (risk difference, -0.19 percentage point [95% CI, -0.49 to 0.11 percentage point]; HR, 0.92 [CI, 0.79 to 1.07]). In men, the corresponding risks were 1.72% and 2.50%, respectively (risk difference, -0.78 percentage point [CI, -1.08 to -0.48 percentage points]; hazard ratio [HR], 0.66 [CI, 0.57 to 0.78]) (P for heterogeneity = 0.004). The absolute risks for death from CRC in women were 0.60% in the screening group and 0.59% in the control group (risk difference, 0.01 percentage point [CI, -0.16 to 0.18 percentage point]; HR, 1.01 [CI, 0.77 to 1.33]). The corresponding risks for death from CRC in men were 0.49% and 0.81%, respectively (risk difference, -0.33 percentage point [CI, -0.49 to -0.16 percentage point]; HR, 0.63 [CI, 0.47 to 0.83]) (P for heterogeneity = 0.014). Limitation: Follow-up through national registries. Conclusion: Offering sigmoidoscopy screening in Norway reduced CRC incidence and mortality in men but had little or no effect in women. Primary Funding Source: Norwegian government and Norwegian Cancer Society.
Authors: Øyvind Holme; Magnus Løberg; Mette Kalager; Michael Bretthauer; Miguel A Hernán; Eline Aas; Tor J Eide; Eva Skovlund; Jørn Schneede; Kjell Magne Tveit; Geir Hoff Journal: JAMA Date: 2014-08-13 Impact factor: 56.272
Authors: Philip Schoenfeld; Brooks Cash; Andrew Flood; Richard Dobhan; John Eastone; Walter Coyle; James W Kikendall; Hyungjin Myra Kim; David G Weiss; Theresa Emory; Arthur Schatzkin; David Lieberman Journal: N Engl J Med Date: 2005-05-19 Impact factor: 91.245
Authors: M Bretthauer; G Gondal; K Larsen; E Carlsen; T J Eide; T Grotmol; E Skovlund; K M Tveit; M H Vatn; G Hoff Journal: Scand J Gastroenterol Date: 2002-05 Impact factor: 2.423
Authors: I K Larsen; T Grotmol; M Bretthauer; G Gondal; G Huppertz-Hauss; B Hofstad; P Efskind; A Jørgensen; G Hoff Journal: Scand J Gastroenterol Date: 2002-07 Impact factor: 2.423
Authors: Cynthia W Ko; V Paul Doria-Rose; Michael J Barrett; Aruna Kamineni; Lindsey Enewold; Noel S Weiss Journal: Int J Colorectal Dis Date: 2019-05-31 Impact factor: 2.571
Authors: Rafael Cardoso; Feng Guo; Thomas Heisser; Harlinde De Schutter; Nancy Van Damme; Mef Christina Nilbert; Jane Christensen; Anne-Marie Bouvier; Véronique Bouvier; Guy Launoy; Anne-Sophie Woronoff; Mélanie Cariou; Michel Robaszkiewicz; Patricia Delafosse; Florence Poncet; Paul M Walsh; Carlo Senore; Stefano Rosso; Valery E P P Lemmens; Marloes A G Elferink; Sonja Tomšič; Tina Žagar; Arantza Lopez de Munain Marques; Rafael Marcos-Gragera; Montse Puigdemont; Jaume Galceran; Marià Carulla; Antonia Sánchez-Gil; María-Dolores Chirlaque; Michael Hoffmeister; Hermann Brenner Journal: Lancet Reg Health Eur Date: 2022-07-06
Authors: Maaike Buskermolen; Andrea Gini; Steffie K Naber; Esther Toes-Zoutendijk; Harry J de Koning; Iris Lansdorp-Vogelaar Journal: Med Decis Making Date: 2018-10-20 Impact factor: 2.583
Authors: Kevin Selby; Christopher D Jensen; Jeffrey K Lee; Chyke A Doubeni; Joanne E Schottinger; Wei K Zhao; Jessica Chubak; Ethan Halm; Nirupa R Ghai; Richard Contreras; Celette Skinner; Aruna Kamineni; Theodore R Levin; Douglas A Corley Journal: Ann Intern Med Date: 2018-09-18 Impact factor: 25.391
Authors: Majid A Almadi; Abed Allehibi; Mohammad A Aljebreen; Othman R Alharbi; Nahla Azzam; Abdulrahman M Aljebreen Journal: Saudi J Gastroenterol Date: 2019 Jan-Feb Impact factor: 2.485
Authors: Rafael Cardoso; Anna Zhu; Feng Guo; Thomas Heisser; Michael Hoffmeister; Hermann Brenner Journal: Dtsch Arztebl Int Date: 2021-04-23 Impact factor: 5.594
Authors: Cristina Sarasqueta; Mª Victoria Zunzunegui; José María Enríquez Navascues; Arrate Querejeta; Carlos Placer; Amaia Perales; Nerea Gonzalez; Urko Aguirre; Marisa Baré; Antonio Escobar; José María Quintana Journal: BMC Cancer Date: 2020-08-14 Impact factor: 4.430